Abstract

The objective of this study was to identify the frequency of the DRB5∗01:08N allele in the Canadian population typed by the Tissue Typing Laboratory of Calgary Laboratory Services in Calgary, Alberta, Canada. The DRB5∗01:08N allele is one of the Common Null Alleles that must be distinguished in external proficiency surveys and routinely in the patient population. DRB5∗01:08N occurs in the presence of the known haplotype DRB1∗1502-DQB1∗05:01. The clinical implication of the presence of a null allele in the bone marrow transplant population is a mismatch that may result in graft vs. host disease or graft rejection. Our laboratory retrospectively reviewed 627 DRB1∗ typings performed in the period between January 2011 and March 2012. Testing was performed using One Lambda LABType SSO medium resolution kits on a Luminex platform. Patients were from the renal, bone marrow and disease association populations. DRB1∗15’s were identified in 7% (42 of 627) of cases. Twenty four per cent of the cases (10 of 42) carried the DRB1∗15:02-DQB1∗05:01 haplotype and typed as DRB1∗01:02/01:08N by SSO low resolution typing. We then tested these 10 cases by One Lambda SSP DRB5 high resolution and the presence of the null allele DRB5∗01:08N was confirmed in 20% (2 of 10 DRB1∗15:02-DQB1∗05:01). The overall incidence of DRB5∗01:08N in Southern Alberta is 0.3% (2 of 627). The low incidence of DRB5∗01:08N in our patient population concurs with other studies in the literature. We currently are performing high resolution SSP typing on all DR∗15:02-DQB1∗05:01 samples that list DRB5∗01:08N as a possibility.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.